Home

600x440 second version

The MRCT Center submitted public comments on the definition of health literacy in Healthy People 2030 to the Secretary of Health and Human Services.

Ethics, Conduct, and Oversight

Representation of Diverse Populations

The MRCT Center submitted public comments on “Enhancing the Diversity of Clinical Trial Populations” to the US FDA on July 30, 2019.

LINK TO MORE

Ethics, Conduct, and Oversight

Research, Development, and Regulatory Roundtable

The August 1, 2019, R3 meeting addressed two topics: (1) Exporting from China for Research: Biospecimens, DNA and Data and (2) Legal and Ethical Issues in the Enrollment of a Company or Institution’s Own Employees and/or Students in Research Studies.

LINK TO MORE

Focus Areas

Our efforts have resulted in the implementation of best practices, greater transparency, and improved safety for research participants in clinical trials.